Medical News
Advancing Liver Cancer Care: Highlights from the BCLC 2024 Meeting
On November 25th and 26th, DiCE virtually attended the Barcelone Clinic Liver Cancer (BCLC) annual conference, which was titled “Forging a Multid...
Tevimbra (tislelizumab) Receives New European Recommendations for Oesophageal and Gastric Cancer
Tevimbra (tislelizumab) receives CHMP recommendations for treating PD-L1-positive oesophageal squamous cell carcinoma and gastric/gastroesophageal ...
New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval
On September 20th, 2024, the European Commission approved zolbetuximab with chemotherapy for advanced Gastric and GastroEsophageal Junction cancers...
The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial
Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial new data presented at the European Society for Medical Oncology (ESMO) 202...
DiCE at ESMO 2024
Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in Barcelo...
EMA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer
Irinotecan hydrochloride trihydrate (Onivyde pegylated liposomal) was approved in March 2024 by the European Medicines Agency (EMA). Indications: N...
Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe
DiCE supports the recommendation for approval of fruquintinib, a new medicine for metastatic colorectal cancer (mCRC). This medicine offers mCRC pa...
OECD Report Confirms Inequalities in Cancer
Cancer causes almost a quarter of all deaths in the EU27, Norway and Iceland, with five new cancer cases diagnosed every minute in 2022. Assessing ...
Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer
In a recently published study conducted by the Netherlands Cancer Institute, patients with gastric (stomach) cancer or gastroesophageal junction (G...
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...
